Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results
08 mai 2018 09h05 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, May 08, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug...
Aquinox to Present at Deutsche Bank 43rd Annual Healthcare Conference
02 mai 2018 12h54 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, May 02, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug...
Aquinox to Present at 2018 Bloom Burton & Co. Healthcare Conference
26 avr. 2018 09h05 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, April 26, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug...
Aquinox to Present at the 17th Annual Needham Healthcare Conference
21 mars 2018 09h00 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug...
Aquinox Pharmaceuticals Announces Year End 2017 Financial Results
12 mars 2018 16h05 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, March 12, 2018 (GLOBE NEWSWIRE) --
Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing...
Aquinox Pharmaceuticals to Announce Year End 2017 Financial Results
05 mars 2018 09h15 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug...
Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor
09 févr. 2018 08h30 HE
|
Aquinox Pharmaceuticals, Inc.
--Enrollment target reached; topline data on track for Q3 2018 announcement-- NEW YORK, Feb. 09, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage...
Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference
02 févr. 2018 06h00 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug...
Aquinox to Host Analyst and Investor Event in New York City
26 janv. 2018 09h05 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Jan. 26, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug...
Aquinox Promotes Lloyd Mackenzie to Chief Operating Officer and Vice President, R&D Operations
15 déc. 2017 09h00 HE
|
Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP) today announced that Lloyd Mackenzie has been promoted, effective immediately,...